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Abstract 1	  
Background. The purpose of this study was to investigate the use of hypoxic sprint interval 2	  
training (SIT) for the improvement of aerobic capacity.  3	  
Method. 27 subjects (mean ± SD), age 21 ± 1 yrs, body mass 72.4 ± 9.7 kg and height 175 ± 4	  
7 cm, completed an V̇O2peak incremental exercise test and a time to exhaustion (TTE) trial 5	  
(80% V̇O2peak) pre and post SIT. Subjects were randomly assigned to one of three groups, 6	  
control (CONT), normoxic (NORM) and hypoxic (FiO2: 0.15) (HYP). The SIT involved 30s 7	  
sprints interspersed with 4min rest. The number of sprints performed progressed from four to 8	  
seven sprints over six sessions separated by 1-2 days rest. Two-way mixed design ANOVA 9	  
was performed to determine changes in baseline measures between conditions.  10	  
Results. V̇O2peak improved (p < 0.05) from pre to post SIT in NORM (11.2 ± 10.8 %) and 11	  
HYP (10.9 ± 6.2 %), but not CONT (0.7 ± 14.3 %). TTE post SIT was significantly improved 12	  
from pre SIT in NORM and HYP but not CONT (CONT = 1 ± 6, NORM = 56 ± 25, HYP = 13	  
34 ± 25%, p < 0.05). Peak and recovery heart rate was significantly lower in NORM than 14	  
HYP as SIT sessions progressed. SpO2 (%) was lower in HYP (86.1 ±4.3%) compared to 15	  
NORM (97.1 ±0.7%), decreasing within all HYP sessions, and increasing with SIT.  16	  
Conclusions. Both hypoxic and normoxic SIT using 30s sprints, progressing in number over 17	  
2 weeks, caused improvement in V̇O2peak and TTE compared to a control. Hypoxic SIT did 18	  
not cause further improvements of this magnitude, indicating that hypoxia based SIT offers 19	  
no additional benefit for improvement of endurance performance. 20	  
Keywords:  21	  
Altitude, Anaerobic, Cycling, Sprint Training, High Intensity. 22	  
 23	  
Introduction 24	  
Sprint interval training (SIT) is a time-efficient method to improve skeletal muscle oxidative 25	  
capacity and exercise performance characterised by repeated sprints at supramaximal 26	  
workloads, interspersed by short recovery bouts 1,2. During repeated sprints oxygen uptake 27	  
(V̇O2) is elevated during recovery to facilitate replenishment of myoglobin, resynthesis of 28	  
creatine phosphate (PCr), and to metabolise lactate and remove intracellular inorganic 29	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phosphates. Oxygen (O2) availability is directly associated with accumulation of anaerobic 1	  
metabolites during sprint training 3.  2	  
 3	  
High intensity training predominantly augments aerobic adaptations, possibly due to the 4	  
increased requirement of aerobic metabolism during training, with high intensity training 5	  
resulting in improved V̇O2 and O2 transport capacity 4,5.  6	  
High intensity intermittent training is a successful method for eliciting improvements in 7	  
aerobic metabolism pathways and endurance performance 6,7. McConnell et al 8 implemented 8	  
a time efficient 2 week training study that elicited significant VO2peak improvement using 9	  
continuous endurance training and intermittent interval training. Literature suggests that 10	  
improvements in aerobic performance are a result of metabolic changes to the muscle, 11	  
notably increased skeletal muscle capillarisation, oxidative and glycolytic enzyme activity 9, 12	  
increased glycogen availability 10,11, muscle buffering capacity through mitochondrial density 13	  
12; and as a result of neural adaptations (motor unit recruitment and synchronisation) 13. It is 14	  
widely acknowledged that high maximal oxygen uptake has a strong correlation with 15	  
endurance performance. It is believed that when short bouts of exercise are repeated, 16	  
phosphocreatine stores deplete 14; and since resynthesis is dependent on availability of O2, 17	  
assumptions can be made that a greater VO2max and O2 delivery to muscles will aid 18	  
rephosphorylation 12.  19	  
 Recent literature has identified that SIT in hypoxia can augment adaptation in both six 2 and 20	  
four 15 week training periods with reduced inspired O2 during SIT limiting aerobic 21	  
contribution to recovery accelerating cardiovascular adaptation. Adaptations were observed 22	  
that six weeks of hypoxic SIT increased phosphofructokinase (PFK) and power output to a 23	  
greater extent than normoxia, with both groups demonstrating improvements in VO2max 24	  
compared to a controls 2. Four weeks of SIT in hypoxia is known to increase repeated sprint 25	  
performance with trends towards improve O2 uptake and attenuation of cerebral 26	  
deoxygenation 15.  27	  
SIT over a two week period is known to improve aerobic capacity 1,16,17, augmenting 28	  
mitochondrial 18 and vascular 19 adaptation, reducing the presence of inflammatory markers 29	  
20, improving insulin sensitivity 21,22 and exercise performance 1,18,22 in both diseased and 30	  
healthy populations 7. It is unknown whether the addition of hypoxia to SIT can augment 31	  
greater adaptation in comparison to normoxia over a two week training period. 32	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Although, not currently investigating individuals with compromised health, this is the first 1	  
study to consider enhancing SIT through environmental modification during a short training 2	  
intervention, and could indicate future directions for developing SIT to optimise rapid 3	  
changes in endurance capacity in clinical, healthy and athletic populations.  4	  
It is hypothesised that SIT in hypoxia will inhibit the aerobic contribution during recovery, 5	  
consequently inducing additional cardiovascular performance gains, further optimising the 6	  
efficiency of SIT as a means for improving endurance performance. 7	  
 8	  
Methods 9	  
Subjects 10	  
Twenty-seven healthy individuals (15 males, 12 females) volunteered to take part in this 11	  
experiment. Subjects were informed of the procedures to be employed in the study and 12	  
associated risks, which had the approval of the University of Brighton Research Ethics 13	  
Committee. All subjects provided written, informed consent. The subjects were non-smokers 14	  
and had not spent time above 2000m in the 2 months prior to the study. Subjects were 15	  
advised to refrain from alcohol and caffeine for 24 hours prior to testing. 16	  
Experimental design 17	  
The 27 subjects were randomly assigned and equally split for number (n = 9) and gender (3 18	  
females) to one of the three intervention groups; a normoxic (NORM) (FiO2: 0.2093) 19	  
environment, a moderate hypoxic (HYP) (FiO2: 0.15) environment and a control (CONT) 20	  
normoxic non training group (Table 1). All testing was carried out in the hypoxic chamber to 21	  
blind subjects and control temperature (19°C) and humidity (40%).  22	  
Familiarisation of the Wingate anaerobic test (WaNT) and time to exhaustion (TTE) was 23	  
performed before any experimental testing began. Pre and post intervention blood was taken 24	  
to measure haematocrit (Hct) and haemoglobin (Hb). Baseline testing included completing a 25	  
V̇O2peak incremental test and a time to exhaustion cycle test (TTE) 48 hours apart and 16 26	  
hours prior to the start of the SIT. SIT using the WaNT was spread over a two week period 27	  
with 24 – 48 hours between each session (see Figure 1). Each training session consisted of 28	  
between four and seven 30s “all out” efforts on a cycle ergometer interspersed with 4min 29	  
warm up/recovery (Figure 1). Heart rate (HR), peripheral arterial oxygen saturation (SpO2) 30	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and rating of perceived exertion (RPE) were measured immediately after each WaNT and 1	  
every minute thereafter during recovery. The number of WaNTs increased over the two week 2	  
period and 48 hours after the final SIT session subjects repeated the V̇O2peak and TTE (figure 3	  
1). 4	  
Preliminary and Post SIT Testing 5	  
Subjects performed an incremental test to volitional exhaustion on a cycle ergometer 6	  
(Monark, model 864, Sweden) to determine V̇O2peak using indirect calorimetry. Starting at 7	  
100w, the power was increased by 25w per minute. Expired gas was collected in the last 45s 8	  
of each stage using Douglas bags (Harvard, Cranlea UK). Heart rate (bts.min-1) and RPE 9	  
(Borg Scale 6 -20) were taken at every stage. Exercise continued until volitional exhaustion.  10	  
HR was monitored by short range telemetry (Polar Electro Oyo, Temple, Finland). VO2peak 11	  
was determined using Douglas bags (Harvard, Cranlea UK) to collect expired air, which was 12	  
analysed with a gas analyser (Servomex 144, Servomex Group Ltd, England). 13	  
A TTE was performed 48 hours later whereby subjects cycled on the ergometer (Monark, 14	  
model 864, Sweden) at a calculated 80% of V̇O2peak, as used by others (1). The test was 15	  
terminated at volitional exhaustion when the subjects’ cadence fell below 40revs.min-1. 16	  
Exercise duration was then determined. 17	  
Pre and post each V̇O2peak test blood was collected using a finger prick pen (Accucheck 18	  
Softclix Pro, Roche, England) after the finger had been cleaned using an alcohol wipe. Using 19	  
heparinised capillary tubes (Hawksley & Sons Ltd, England) and clay at each end, the blood 20	  
was spun in a centrifuge (Hematospin 1300, Hawksley & Sons Ltd, England) at 1000rpm for 21	  
1.5min to calculate the haematocrit. To measure haemoglobin, blood was placed on a 22	  
Hemocue slide (B-Hemoglobin Photometer, Hemocue, Sweden) and using the Hemocue, 23	  
haemoglobin device (B-Hemoglobin Microvettes, Hemocue, Sweden). 24	  
Sprint Interval Training 25	  
Subjects gave a 30s “all out” effort on a cycle ergometer (Monark, model 864, Sweden) 26	  
against a resistance of 0.075kg.kg-1 body mass, from a rolling start of 70revs.min-1. The 27	  
subjects were verbally encouraged throughout. The WaNT's were interspersed with a 4min 28	  
warm up/active recovery period of cycling at 60W. Power measures were recorded using 29	  
Monark Anaerobic Test software (Monark, Sweden) continuously throughout the sprints. 30	  
6	  
	  
The normobaric hypoxic environment was achieved using a purposed built nitrogen-enriched 1	  
chamber (Altitude Centre, London). Peripheral arterial oxygen saturation (SpO2) and heart 2	  
rate was monitored using a finger pulse oximeter (Nonin 2500, Nonin Medical Inc., USA) 3	  
every minute during recovery. 4	  
Statistical analysis 5	  
Data were tested for normality, skewness and kurtosis. Data were normally distributed unless 6	  
otherwise stated. A Two Way Mixed Design ANOVA was performed separately on each of 7	  
the independent variables; VO2peak, TTE, Hb and Hct, to calculate whether there was a 8	  
significant change between the three conditions. When significant, post hoc analysis was 9	  
performed using the Bonferroni corrected t-test and Tukey’s HSD. All data were reported as 10	  
Mean ± Standard Deviation. All statistical tests followed a significance level of p<0.05. The 11	  
statistical package used was SPSS (SPSS Inc. Chicago, USA, version 20.0). 12	  
Results 13	  
Exercise Performance 14	  
V̇O2peak (L.min-1) increased from pre to post test (f = 13.659, p = 0.001) overall, and different 15	  
for the pre-post*group interaction (f = 3.684, p = 0.040). Post hoc analysis observed increases 16	  
for HYP (p = 0.003; +10.9%; 3.13 ± 0.95 to 3.49 ± 1.14 L.min-1) and NORM (p = 0.004; 17	  
+11.2%; 2.91 ± 0.42 to 3.26 ± 0.71 L.min-1), but not CONT (p = 0.935; +0.7%; 3.02 ± 0.93 to 18	  
3.01 ± 0.94 L.min-1) (Figure 2). 19	  
TTE (min) increased from pre to post test (f = 39.109, p < 0.001) overall, and was different 20	  
for the pre-post*group interaction (f = 10.310, p = 0.001). Post hoc analysis observed 21	  
increases as occurring pre-post HYP (p < 0.001; +34.8%; 8.0 ± 3.1 to 10.5 ± 4.2 min) and 22	  
NORM (p < 0.001; +56.3% 6.56 ± 2.1 to 10.0 ± 3.0 min) but not CONT (p = 0.962; 1.6%; 23	  
9.0 ± 3.6 to 9.0 ± 3.2 min) (Figure 3).  24	  
The mean PPO (W.kg-1) of the first four sprints was different from pre to post test (f = 25	  
15.948, p = 0.001) overall, but not for the pre-post*group interaction (f = 3.552, p = 0.001). 26	  
Post hoc analysis observed increases from pre-post in NORM (p = 0.001; +16.2%; 8.4 ± 2.2 27	  
to 9.4 ± 1.9 W.kg-1) but not HYP (p = 0.155; +5.1%; 8.9 ± 1.7 to 9.2 ± 1.7 W.kg-1) see Figure 28	  
5. 29	  
Blood markers 30	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Hb (g.dL-1) was not different from pre to post test (f = 2.247, p = 0.147) overall, or for the 1	  
pre-post*group interaction (f = 3.044, p = 0.066) for HYP (14.9 ± 1.7 to 15.4 ± 1.6 g.dL-1), 2	  
NORM (14.6 ± 1.4 to 14.7 ± 1.2 g.dL-1), and CONT 14.7 ± 1.3 to 14.5 ± 1.4 g.dL-1). 3	  
Hct (%) was not different from pre to post test (f = 0.803, p = 0.379) overall, or for the pre-4	  
post*group interaction (f = 0.102, p = 0.903) for HYP (45.4 ± 3.5 to 45.9 ± 3.8 %), NORM 5	  
(44.2 ± 2.4 to 44.3 ± 3.3 %), and CONT 43.5 ± 3.2 to 43.7 ± 2.9 %). 6	  
Physiological markers 7	  
Peak HR (b.min-1) was different overall between HYP (175.5 ± 2.7 b.min-1) compared to 8	  
NORM (172.2 ± 3.1 b.min-1) (f = 31.523; p = 0.000), significant differences were also 9	  
observed between SIT sessions (f = 5.461; p = 0.000) and for the group*SIT interaction (f = 10	  
2.918; p = 0.021). Post-hoc analysis observed HYP to be significantly higher than NORM 11	  
during SIT 1 (p = 0.039; HYP 176.2 ± 4.4, NORM 172.6 ± 1.4 b.min-1), SIT3 (p = 0.049; 12	  
HYP 176.8 ± 2.7, NORM 173.4 ± 2.0 b.min-1), SIT4 (p = 0.000; HYP 174.9 ± 2.5, NORM 13	  
169.3 ± 2.0 b.min-1), and SIT5 (p = 0.000; HYP 176.3 ± 2.4, NORM 170.1 ± 1.1 b.min-1), but 14	  
not SIT2 (p = 0.336; HYP 172.8 ± 1.8, NORM 171.3 ± 2.3 b.min-1) or SIT6 (p = 0.867; HYP 15	  
176.0 ± 1.6, NORM 175.8 ± 1.1 b.min-1). No differences were observed between SIT 16	  
sessions within each group. 17	  
Recovery HR (b.min-1) was significantly different overall between groups, HYP (140.7 ± 5.0 18	  
b.min-1) compared to NORM (135.6 ± 4.9 b.min-1) (f = 21.568; p = 0.000), significant 19	  
differences were also observed between SIT sessions (f = 2.890; p = 0.022) but not the 20	  
group*SIT interaction (f = 2.918; p = 0.052). Post-hoc analysis observed HYP to be 21	  
significantly higher than NORM during SIT 1 (p = 0.001; HYP 146.7 ± 4.6 NORM 135.5 ± 22	  
4.8 b.min-1), SIT4 (p = 0.031; HYP 139.0 ± 3.8, NORM 133.3 ± 4.4 b.min-1), SIT5 (p = 23	  
0.003; HYP 140.3 ± 3.5, NORM 132.4 ± 6.0 b.min-1) and SIT6 (p = 0.025; HYP 142.5 ± 4.0, 24	  
NORM 137.1 ± 3.0 b.min-1), but not SIT2 (p = 0.496; HYP 137.1 ± 6.0, NORM 135.1 ± 4.6 25	  
b.min-1) or SIT3 (p = 0.621; HYP 139.5 ± 5.2, NORM 140.9 ± 2.7 b.min-1). The only 26	  
difference between SIT sessions within each group was SIT1 as different to SIT2 (p = 0.028) 27	  
within HYP.	  28	  
SpO2 (%) was significantly different overall between groups, HYP (86.1 ± 4.3 %) compared 29	  
to NORM (97.1 ± 0.7 %) (f = 2677.786; p = 0.001), significant differences were also 30	  
observed between SIT sessions (f = 4.710; p = 0.001) and for the group*SIT interaction (f = 31	  
8	  
	  
4.423; p = 0.001). Post-hoc analysis observed HYP to be significantly lower than NORM in 1	  
all SIT sessions (p = 0.001). No difference existed between any SIT sessions in NORM. 2	  
Significant differences were observed within sessions with 1.1 (88.2 ± 3.0 %) greater than 1.3 3	  
(82.9 ± 4.6 %; p = 0.009) and 1.4 (81.1 ± 5.0; p = 0.001), 2.1 (88.4 ± 3.4 %) from 2.4 (82.0 ± 4	  
4.8 %; p = 0.001 %) and 2.5 (81.7 ± 4.5; p = 0.001), 3.1 (88.9 ± 3.8 %) from 3.5 (83.3 ± 3.9 5	  
%; p = 0.004), 4.1 (89.4 ± 2.7) from 4.5 (83.2 ± 4.0 %; p = 0.001 %) and 4.6 (82.7 ± 3.7 %; p 6	  
= 0.001), 5.1 (90.6 ± 2.6) from 5.6 (84.1 ± 3.5 %; p = 0.001 %) and 6.1 (91.6 ± 1.7 %) from 7	  
6.5 (86.1 ± 2.6 %; p = 0.006), 6.6 (85.2 ± 3.2 %; p = 0.001) and 6.7(84.2 ± 3.1 %; p = 0.001). 8	  
No difference was observed between the first sprint of any session (p = 1.000) although a 9	  
trend existed whereby SpO2 increased daily (Figure 4). 10	  
Discussion 11	  
The main purpose of this study was to examine the influence on 2 weeks of SIT in normoxia 12	  
and hypoxia on endurance capacity. To this end, the training protocol was designed to 13	  
enhance aerobic performance measures 1,23 with the inclusion of a hypoxic condition, 14	  
designed to stress the aerobic metabolic contribution to SIT. 15	  
There were no significant changes in TTE or V̇O2peak pre and post intervention for the control 16	  
group. V̇O2peak and TTE increased in HYP and NORM after SIT however no difference was 17	  
observed between HYP and NORM. These data contradict our hypothesis that additional 18	  
physiological strain of hypoxia during SIT, increases aerobic contribution during recovery, 19	  
consequently inducing additional cardiovascular performance gains. Six sessions of SIT may 20	  
not have provided enough additional training stimuli for our HYP group to benefit from the 21	  
additional physiological strain, and a longer training period may have yielded statistically 22	  
significant differences between NORM and HYP 2,15. 23	  
Longer duration studies 24 have also shown a significant increase in V̇O2peak from 51.06 to 24	  
54.5 ml.kg-1.min-1 over 7 weeks of SIT (p<0.05). Burgomaster et al 25 demonstrated that 25	  
V̇O2peak improved following 6week of SIT. Studies that implemented SIT for 2 weeks 15,18 26	  
found significant improvement in time trial performance in agreement with our data. 27	  
Burgomaster et al 1 also found 2 weeks SIT to improve TTE. In the present study TTE did not 28	  
improve to the extent of that seen by Burgomaster’s group1. Improvement in TTE ranged 29	  
from 81 to 169% 1, where as the current study reports smaller improvement range for NORM 30	  
(20 – 104%) and HYP (3 – 62%). Differences may be a consequence of the poorer training 31	  
9	  
	  
status of those in the current study, finding the considerable training intensity too severe in 1	  
latter sprints.  2	  
Burgomaster et al 1 implied that the training-induced increases in mitochondrial potential, 3	  
which was measured by citrate synthase activity. Macdougall et al 24 also found significant 4	  
improvement in aerobic performance measures with SIT, attributing this to improvements in 5	  
oxidative and glycolytic enzyme activity. The precise mechanisms behind endurance 6	  
performance are complex and results from other studies suggest that SIT can stimulate a 7	  
range of adaptations that facilitate performance: Increases of resting glycogen 4, changes in 8	  
enzymatic activity  24,27,28, sarcoplasmic reticulum function and COX activity 17. As expected, 9	  
blood parameters were not altered by the hypoxic stimulus, as such short durations and a 10	  
relatively low altitude dosage 30 was not likely to induce erythropoiesis, although 11	  
erythropoietin increase would be possible it was not measured 31.  12	  
Oxygen availability has a significant influence on the rate of V̇O2 at the onset of high 13	  
intensity exercise 23, and specifically to this study, hypoxic conditions result in the slowing of 14	  
V̇O2 kinetics. This increases the magnitude of the O2 deficit incurred during each sprint and 15	  
places more demand on anaerobic sources to maintain ATP production. This increased rate of 16	  
fatigue under hypoxic conditions may be the result of inorganic phosphate (Pi) accumulation 17	  
during each sprint and the reduced rate of removal during recovery (4). Having not tested V̇O2 18	  
throughout the SIT, the metabolic differences between HYP and NORM are difficult to 19	  
decipher, however HR would give an indication of physiological effort during SIT. Mean HR 20	  
was significantly greater in HYP than NORM, demonstrating greater autonomic requirement 21	  
to recover from a hypoxic sprint. After each 4min recovery HR during HYP progressively 22	  
increased over each SIT, recovery was not achieved and O2 deficit accumulated, this provides 23	  
insight into the mechanism for differences in PPO between HYP and NORM during SIT 24	  
session 6, where insufficient recovery was made in HYP 34 and therefore PPO was 25	  
maintained, not improved.  26	  
SpO2 reduced in HYP, meaning a reduction in O2 availability at the cellular level for the 27	  
recovery processes as further evidenced by a greater HR during recovery. The trend of this 28	  
response demonstrates an acute acclimatisation to the hypoxic training over the six sessions, 29	  
whereby SpO2 was significantly greater at respective time points in the latter sessions. This 30	  
may be well documented in longer simulated acclimatisation training. Yet this response may 31	  
be of use to those considering short term, high intensity hypoxic training for improvement in 32	  
10	  
	  
altitude tolerance. This high intensity, simulated altitude acclimatisation training warrants 1	  
further research.  2	  
The explanation for non-significant results for the HYP group could be attributed to the 3	  
strength of hypoxia. HR and RPE were high throughout the 2 weeks and recovery periods 4	  
were not sufficient in comparison to NORM, potentially resulting in a reduced anaerobic 5	  
power and training load across the sprints. While it is possible that the hypoxic stimulus was 6	  
too severe, it could also be suggested that the recovery phases were too short. Yet altitude 7	  
training classically uses moderate hypoxia, approximately ~2,500m 35 (FiO2: 0.15) allowing 8	  
for a sufficient training intensity. It is not thought that the normobaric nature of the exposure 9	  
is different to hypobaric hypoxia due to the short durations of exposure 36. Future research 10	  
may wish to consider such hypoxic SIT at higher inspired oxygen fractions to allow greater 11	  
aerobic recovery for consecutive sprints.  12	  
Morton & Cable 37 studied the use of moderate to high intensity 30min cycle training in 13	  
normobaric hypoxia (2750m) over 4weeks. V̇O2peak, OBLA, mean power and peak power 14	  
increased with both normoxic and hypoxic training, yet no differences were seen between 15	  
normoxic and hypoxic training conditions. These findings are similar to that of the current 16	  
study whereby improvements in endurance were seen, yet hypoxia offered no additional 17	  
benefit than to that of high intensity normoxic training. Roels et al 38 used intermittent 18	  
hypoxic (FiO2: 0.14) training and found a similar cardiovascular improvement with no 19	  
additional benefit of hypoxic training. Additionally, Roels et al 38 conclude that this use of 20	  
training has greater implications for short term acclimatisation to altitude for altitude 21	  
performance, as supported by the SpO2 data presented within this study. 22	  
The recognition of high intensity exercise is growing, not only for performance training but 23	  
for weight management and various diseased populations. The intensity of this training 24	  
presents some significant feasibility and safety implications for these populations 7. Hypoxic 25	  
SIT only exacerbates the difficulty of this training modality and therefore should not be 26	  
considered by most. 27	  
The use of hypoxia or altitude as a training stimulus can be difficult to evaluate due to the 28	  
individual responses to a hypoxic or altitude environment. As a result, the current study is 29	  
limited by the relatively small number of recreationally active participants. Further, 30	  
measurement of power outputs for training loads throughout the SIT sessions would have 31	  
been a useful tool for evaluating training intensities managed for each environment. For 32	  
11	  
	  
greater interpretation of mechanisms future work may investigate cellular or inflammatory 1	  
responses to hypoxic SIT. Future research evaluating sprint or recovery durations for hypoxic 2	  
SIT may well discover beneficial training methods.  3	  
Conclusion 4	  
Both normoxic and hypoxic sprint interval training (SIT) using 30s sprints interspersed with 5	  
4min rest progressing in number over 2 weeks, caused improvement in TTE and VO2peak. 6	  
This study indicates that hypoxia based SIT offers no additional benefit for improvement of 7	  
endurance performance. 8	  
 9	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 1	  
Figure Captions 2	  
Figure 1 Schematic of the study protocol 3	  
Figure 2 Absolute V̇O2peak changes shown across all groups and between conditions. Values 4	  
are ± SD. *denotes significant difference within group. (p < 0.05). HYP = hypoxic training, 5	  
(FiO2: 0.15) NORM = normoxic training, (FiO2: 0.2093), CONT = no training.	  6	  
Figure 3 Time to Exhaustion changes shown across all groups and between conditions. 7	  
Values are ± SD. *denotes significant difference within trial (p<0.05). HYP = hypoxic 8	  
training, (FiO2: 0.15) NORM = normoxic training, (FiO2: 0.2093), CONT = no training. 9	  
Figure 4 SpO2 (%) during sprint interval training (SIT). * denotes significant difference (p < 10	  
0.05) from first sprint within day. Values are ± SD. # denotes significant difference (p < 0.05) 11	  
between conditions. HYP = hypoxic training, (FiO2: 0.15) NORM = normoxic training, 12	  
(FiO2: 0.2093) 13	  
 14	  
Table Captions 15	  
Table 1:Subject characteristics. Values are means ± SD 16	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